Sunday, December 4, 2022

Nevro Announces Director Appointment- Sri Kosaraju

Nevro Corp. (NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, today announced that Sri Kosaraju has been appointed as a member of the Board of Directors (the “Board”), effective August 31, 2021.

“We are delighted to have Sri join our Board of Directors,” said D. Keith Grossman, Chairman, President and CEO of Nevro. “Sri’s significant experience in leading high-growth life science and medical technology companies as well as his deep background in the healthcare industry will make him a valuable addition to our board. We look forward to Sri’s contributions to our Board of Directors and the continuing success of Nevro.”

“I’m excited to be joining Nevro’s Board,” said Mr. Kosaraju. “I have high respect for Keith and his leadership. Furthermore, I look forward to working with this world-class Board to support the Nevro team as it pursues impactful products for patients and continues to develop attractive long-term growth opportunities for its stakeholders.”

Mr. Kosaraju currently serves as the Chief Executive Officer and President of Inscripta, Inc., the digital genome engineering company, a position he has held since October 2020. Prior to joining Inscripta, Mr. Kosaraju was President of Penumbra, Inc., which he joined as CFO in May 2015. Earlier, Mr. Kosaraju spent 16 years at J.P. Morgan, where he was most recently Head of Healthcare Equity Capital Markets and Co-Head of Technology Equity Capital Markets. While at J.P. Morgan, he worked closely with and advised many emerging, high-growth life science and tech companies. In addition to serving on the Board of Directors for Inscripta, Mr. Kosaraju also currently serves on the Board of Directors and is the Chair of the Audit Committee of 10x Genomics, Inc. and is on the Board of the non-profit Testing for America.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Our Sister Publication

Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy